Registro:

Referencias:

• Furie, B., Furie, B.C., The molecular bases of blood coagulation (1991) Hematologyc Basic Principles and Practice. 3rd Ed., p. 1213. , Hoffman R, Benz E, Shattil S, Furie B, Cohen H Ed. London: Churchill
• Sánchez Avalos, J.C., Fisiología de la hemostasia. En manual de hemostasia y trombosis (1990) Buenos Aires, pp. 3-17. , Kordich L, et al. (eds)
• Hemker, H.C., Thrombin generation, an essential step an haemostasis and thrombosis (1993) Haemostasis and Thrombose, pp. 477-490. , A. Bloom et al (eds). Edinburg: Churchill Livingstone
• Fenton J.W. II, Thrombin functions and antithrombotic intervention (1995) Thromb Haemost, 74 (1), pp. 493-498
• Guillin, M.C., Bezeaud, A., Bouton, M.C., Jandrot-Perrus, M., Thrombin specificity (1995) Thromb Haemost, 74 (1), pp. 129-133
• Brinkhous, K.M., Smith, H.P., Warner, E.D., Seegers, W.H., The inhibition of blood clotting. An unidentified substance which acts in conjunction with heparin to prevent conversion of prothrombin to thrombin (1939) Am J Physiol, 125, pp. 683-687
• Abildgaard, U., Purification of two progressive antithrombins of human plasma (1967) Scand J Lab Clin Invest, 19, pp. 190-195
• Briginshaw, G.F., Shanberge, U.N., Identification of two distinct heparin cofactors in human plasma. Separation and partial purification (1974) Arch Biochem Biophys, 161, pp. 683-690
• Tollefsen, D.M., Blank, M.K., Detection of a new Heparin-dependent inhibitor of Thrombin in human plasma (1981) J Clin. Invest, 68, pp. 589-596
• Tollefsen, D.M., Majerus, D.W., Blank, M.K., Heparin cofactor II. Purification and properties of a heparin dependent inhibitor of thrombin in human plasma (1982) J Biol Chem, 257, pp. 2162-2169
• Blinder, M.A., Marasa, J.C., Reynolds, C.H., Deaven, L.L., Tollefsen, D.M., Heparin Cofactor II: CDNA sequence, chromosome localisation, restriction fragment length polymorphism, and expression in Escherichia coli (1988) Biochemistry, 27, pp. 752-759
• Sié, P., Dupouy, D., Pichon, J., Boneu, B., Turnover study of Heparin Cofactor II in healthy man (1985) Thromb Haemost, 54 (3), pp. 635-638
• Herzog, R., Lutz, S., Blin, N., Marasa, J.C., Blinder, M.A., Tollefsen, D.M., Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11 (1991) Biochemistry, 30, pp. 1350-1357
• Derechin, V.M., Blinder, M.A., Tollefsen, D.M., Substitution of arginine for leucine 444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition (1990) J Biol Chem, 265, pp. 5623-5628
• Ragg, H., Ulshofer, T., Gerewitz, J., On the activation of human leuserpin 2. A thrombin inhibitor by glycosaminoglycans (1990) J Biol Chem, 265, pp. 5211-5218
• Tollefsen, D.M., The interaction of glycosaminoglycans with heparin cofactor II (1994) Annals New York Academy of Sciences, 714, pp. 21-31
• Church, F.C., Treabor, R.E., Sherrill, G.B., Whinna, H.C., Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II (1987) Biochem Biophys Res Commun, 148, pp. 362-368
• Church, F.C., Pratt, C.W., Treanor, R.E., Whinna, H.C., Antithrombotic action of phosvitin and other phosphate containing polyaniones is mediated by heparin cofactor II (1988) FEBS Lett, 237, pp. 26-30
• Church, F.C., Meade, J.B., Treanor, R.E., Whinna, H.C., Antithrombin activity of fucoidan: The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin (1989) J Biol Chem, 264, pp. 3618-3623
• Hayakawa, Y., Hayashi, T., Hayashi, T., Niiya, K., Sakuragawa, N., Selective activation of heparin cofactor II by a sulfated polysaccharide isolates from the leaves of Artemisia princeps (1995) Blood Coag Fibrinol, 6, pp. 643-649
• Tollefsen, D.M., Activation of heparin cofactor II by heparin and dermatan sulfate (1984) Nouv Rev Fr Hematol, 26, pp. 233-237
• Rydel, T.J., Ravichandran, K.G., Tulinsky, A., Bode, W., Huber, R., Roistsch, C., Fenton J.W. II, The structure of a complex of recombinant hirudin and human alpha thrombin (1990) Science, 249, pp. 277-280
• Sheehan, J.P., Wu, Q., Tollefsen, D.M., Sadler, J.E., Mutagenesis of thrombin selectively modulates inhibition by serpins Heparin Cofactor II and Antithrombin III (1993) J Biol Chem, 268, pp. 3639-3645
• Tollefsen, D.M., Insight into the mechanism of action of heparin cofactor II (1995) Thromb Haemost, 74 (5), pp. 1209-1214
• Sheehan, J.P., Tollefsen, D.M., Sadler, J.E., Heparin Cofactor II is regulated allosterically and not primarily by templates effects: Studies with mutant thrombins and glycosaminoglycans (1994) J Biol Chem, 269, pp. 32747-32751
• Thumberg, L., Backstrom, G., Lindahl, U., Further characterization of the antithrombin-binding sequence in heparin (1982) Carbohydr Res, 100, pp. 393-410
• Olson, S.T., Björk, I., Role of protein conformational changes, surface approximation and proteins cofactors in heparinaccelerated antithrombin-proteinase reactions (1992) Heparin and Related Polysaccharides, 313, pp. 155-165. , Lane D.A., Björk I, Lindahl U., eds. New York: Plenum Press
• Prat, C.W., Whinna, H.C., Church, F.C., A comparation of three heparin-binding serine protease inhibitors (1992) J Biol Chem, 267, pp. 8795-8801
• Olds, R.J., Lane, D.A., Mille, B., Chowdhury, V., Lay Thein, S., Antithrombin: The principal inhibitor of thrombin (1994) Seminars in Thrombosis and Hemostasis, 20, pp. 353-372
• Bovill, E.G., Tracy, R.P., Hayes, T.E., Jenny, R.J., Bhushan, F.H., Mann, K.G., Evidence that meizothrombin is an intermediate product in the clotting of whole blood (1995) Arterioscler Thromb Vasc Biol, 12, pp. 754-758
• Han, J.H., Coté, H.C.F., Tollefsen, D.M., Inhibition of meizothrombin and meizothrombin (desF1) by Heparin Cofactor II (1997) J Biol Chem, 272, pp. 28660-28665
• Bendayan, P., Boccalon, H., Dupouy, D., Bomeau, B., Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins (1994) Thromb Haemost, 71, pp. 567-582
• Tollefsen, D.M., Pestka, C.A., Modulation of heparin cofactor II activity by histidinerich glycoprotein and platelet factor 4 (1985) J Clin Invest, 75, pp. 496-501
• Preissner, K.T., Sie, P., Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thfombin-heparin cofactor II complex (1988) Thromb Haemosf, 60 (3), pp. 399-406
• Kounnas, M.Z., Church, F.C., Argraves, W.S., Strickland, D.K., Cellular internalisation and degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and α1Antytrypsin-Trypsin complexes is mediated by the low density lipoprotein receptor-relates protein (1996) J Biol Chem, 271, pp. 6523-6529
• De Boer, H.C., Preissner, K.T., Bouma, B.N., De Groot, P.G., Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin (1992) J Biol Chem, 267, pp. 2264-2268
• Preissner, K.T., De Boer, H., Pannekoek, H., De Groot, P.G., Thrombin regulation by physiological inhibitors: The role of vitronectin (1996) Seminars in Thrombosis and Hemostasis, 22, pp. 165-172
• Preissner, K.T., Structure and biological role of vitronectin (1991) Annu Rev Cell Biol, 7, pp. 275-310
• Liu, L., Dewar, L., Song, Y., Kulczycky, M., Blajchman, M.A., Fenton J.W. II, Inhibition of thrombin by antithrornbin III and heparin cofactor II in vivo (1995) Thromb Haemost, 73 (3), pp. 405-412
• Linhart, R., Hakim, A., Liu, Kim, Y.S., Fareed, J., Molecular profile and mapping of Dermatan sulfates from different origins (1991) Sem in Thromb and Hemostas, 71, pp. 15-22
• Hampson, I.N., Gallagher, J.Y., Separation of radiolabelled glycosaminoglycan oligosaccharides by poliacrilamide-gel; electrophoresis (1984) Biochem J, 221, pp. 697-705
• Delorme, M.A., Saees, N., Sevick, A., Mitchell, L., Berry, L., Johnston, M., Andrew, M., Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis (1993) Blood, 82, pp. 3380-3385
• Andrew, M., Mitchel, L., Berry, L., Paes, B., Delorme, M., Ofosu, F., Burrows, R., Khambalia, B., An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant women and her fetus (1992) J Clin Invest, 89, pp. 321-326
• Pradoi, P., Meduri, F., Cuppini, S., Toniato, A., Zangrandi, F., Polistena, P., Gianese, F., Maffei Faccioli, A., Dermatan sulfate: A safe approach to prevention of postoperative deep vein thrombosis (1992) Br J Surg, 79, pp. 505-509
• Agnelli, G., Cosmi, B., Di Filippo, P., Ranucci, V., Veschi, F., Lobgetti, M., Renga, C., A, R., A randomised, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture (1992) Thromb Haemost, 67, pp. 203-208
• Boneu, B., Glycosaminoglycans: Clinical use (1996) Sem in Thromb Hemost, 22, pp. 209-212
• Sie, P., Dupouy, D., Pichon, J., Boneu, B., Constitutional heparin cofactor II deficiency associated with recurrent thrombosis (1985) Lancet, 2, pp. 414-416
• Duboscq, C., Quintana, I., Barrios, J., Kordich, L., Heparin Cofactor II in diabetic patients (1994) Blood Coag Fibrinol, 5, pp. 201-204
• Conard, J., Bara, L., Horellou, M.H., Samama, M.M., Bobine or human thrombin in amidolytic ATIII assays. Infuence of heparin cofactor II (1986) Thromb Res, 41, pp. 873-878
• Lane, D.A., Mannucci, P.M., Bauer, K.A., Bertina, R.M., Bochkov, N.P., Boulyjenkov, V., Inherited thrombophilia: Part 1 (1996) Thromb Haemost, 76 (5), pp. 651-662
• Seligsohn, U., Zivelin, A., Thrombophilia as a multigenic disorder (1997) Thromb Haemost, 78, pp. 297-301
• Tran, T.H., Marbet, G.A., Duckert, F., Association of hereditary heparin cofactor II deficiency with thrombosis (1985) Lancet, 11, pp. 413-414
• Simioni, P., Lazzaro, A.R., Coser, E., Salmistraro, G., Girolami, A., Hereditary heparin cofactor II deficiency and thrombosis: Report of six patients belonging to two separate kindreds (1990) Blood Coag Fibrinol, 1, pp. 351-356
• Berina, R.M., Van der Linden, I.K., Engesser, L., Muller, H.P., Brommer, J.P., Hereditary heparin cofactor II deficiency and the risk of development of thrombosis (1987) Thromb Haemost, 57, pp. 196-200
• Blinder, M., Anderson, T.R., Abildgaard, U., Tollefsen, D.M., Heparin Cofactor II Oslo (1989) The Journal of Biologycal Chemistry, 264, pp. 5128-5133
• Matsuo, T., Kario, K., Sakamoto, S., Yamada, T., Miki, T., Hirase, T., Hereditary heparin cofactor II deficiency and coronary artery disease (1992) Thromb Res, 65, pp. 495-497
• Bernardi, F., Legnani, C., Micheletti, F., Lunghi, B., Ferraresi, P., Palareti, G., A Heparin Cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects (1996) Thromb Haemost, 76 (4), pp. 505-509
• Tollefsen, D.M., Pestka, C., Heparin Cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure (1985) Blood, 66, pp. 769-774
• Vinazzer, H., Stocker, K., Heparin Cofactor II: Experimental approach to a new assay and clinical results (1991) Thrombosis Research, 61, pp. 235-241
• Porter, J.B., Young, L., Mackie, I.J., Marshall, L., Machin, S.J., Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II (1993) British Journal of Haematology, 83, pp. 459-465
• Sandset, P.M., Hellgren, M., Uvebrandt, M., Bergström, H., Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy (1989) Thromb Res, 55, pp. 665-670
• Mackie, I.J., Segal, H., Burren, T., Gallimore, M., Walshe, K.J., Robinson, G., Machin, S.J., Heparin Cofactor II levels are increased by the use of combined oral contraceptives (1990) Blood Coag Fibrinol, 1, pp. 647-651
• Toulon, P., Lamine, M., Lejev, I., Guez, T., Holleman, M.E., Sereni, D., Sicard, D., Heparin cofactor II deficiency in patients infected with the human inmmunodeficiency virus (1993) Thromb Haemost, 70, pp. 730-735
• Sie, P., Meguira, B., Boissou, F., Boneu, B., Barthe, P., Plasma Levels of Heparin Cofactor II in Nephrotic Syndrome of Children, , Tesis doctoral de Pierre Sie. Université Paris VII. Uer Medicine St Louis. Lariboisière
• Toulon, P., Vitoux, J.F., Capron, L., Roncato, M., Fiessinger, J.N., Aiach, M., Heparin Cofactor II in Patients with Deep Venous Thrombosis under Heparin and Oral Anticoagulant Therapy, , Tesis doctoral de Pierre Sie. Université Paris VII. Uer Medicine St Louis. Lariboisière
• Matsuo, T., Kobayashi, H., Kadowaki, S., Diabetes mellitus as a prethrombotic state: Both heparin cofactor II (HCII) and antithrombin III (ATIII) were depresed in diabetes mellitus (1989) Thromb Haemost, 62, p. 1442. , abstract
• Recomendación aprobada sobre teoría de los valores de referenda (1988) Acta Bioquímica Clínica Latinoamericana, 22 (3), p. 443
• Rodeghiero, F., Tosetto, A., The VITA proyect: Population-based distributions of Protein C. Antithrombin III. Heparin cofactor II and Plasminogen relationship with physiological variables and establishment of reference ranges (1996) Thromb Haemost, 76, pp. 226-233
• Tran, T.H., Duckert, F., Heparin cofactor II determination levels in normal and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation (1984) Thromb Haemost, 52, pp. 112-116
• Anderson, T.R., Larsen, M.L., Handeland, G.F., Abildgaard, U., Heparin cofactor II activity in plasma: Application of an automated assay method to the study of a normal adult population (1986) Scand J Haematol, 36, pp. 96-102
• Abildgaard, U., Larsen, M.L., Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma (1984) Thromb Res, 35, pp. 257-266
• Toulon, P., Jacquot, C., Capron, L., Frydman, M.O., Vignon, D., Aiach, M., Antithrombin III and Heparin Cofactor II in patients with chronic renal failure undergoing regular hemodialysis (1987) Thromb Haemost
• Griffith, M.J., Thompson, G.F., McNeely, T.B., Marbet, G.A., White, G.C., Measurement of Heparin Cofactor II levels in human plasma (1984) Circulation, 70, p. 361
• Duboscq, C., Quintana, I., Rossi, E., Kordich, L., Cofactor II de la heparina, valores de referencia, consumo en presencia de distintos glicosaminoglicanos (1995) Acta Bioquímica Clínica Latinoamericana, 29 (4), pp. 485-492
• Definition for sepsis an organ failure and guidelines for the use of innovative therapies in sepsis (1992) Chest, 101, p. 1644. , ACCP/SCCM consensus conference
• Kordich, L., Sassetti, B., Lago, O., Modificación de los factores de coagulación y ATIII por acción de enzimas leucocitarias (1978) Medicina (Buenos Aires), 38, pp. 840-844
• Sie, P., Dupouy, D., Dol, F., Boneu, B., Inactivation of Heparin Cofactor II by Polymorphonuclear Leukocytes

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------